The risk of tuberculosis in children after close exposure: a systematic review and individual-participant meta-analysis.
The Lancet. ; 395(10228):973-984.
Decision Analytics and Optimization in Disease Prevention and Treatment.
; :59-79.
The impact of digital health technologies on tuberculosis treatment: a systematic review.
European Respiratory Journal. ; 51(1):1701596-.
A Likelihood Approach for Real-Time Calibration of Stochastic Compartmental Epidemic Models.
PLOS Computational Biology. ; 13(1):e1005257-.
Using Chemical Reaction Kinetics to Predict Optimal Antibiotic Treatment Strategies.
PLOS Computational Biology. ; 13(1):e1005321-.
A Multistrain Mathematical Model To Investigate the Role of Pyrazinamide in the Emergence of Extensively Drug-Resistant Tuberculosis.
Antimicrobial Agents and Chemotherapy. ; 61(3):-.
The contributions of Steve Lawn to the science, advocacy and policy of HIV-associated TB.
The International Journal of Tuberculosis and Lung Disease. ; 20(12):1563-1564.
The prospective evaluation of the TB strain typing service in England: a mixed methods study.
Thorax. ; 71(8):734-741.
Within-Host Heterogeneity of.
Journal of Infectious Diseases. ; 213(11):1796-1799.
Use of Lot Quality Assurance Sampling to Ascertain Levels of Drug Resistant Tuberculosis in Western Kenya.
PLOS ONE. ; 11(5):e0154142-.
The transmission of Mycobacterium tuberculosis in high burden settings.
The Lancet Infectious Diseases. ; 16(2):227-238.
Identifying Hotspots of Multidrug-Resistant Tuberculosis Transmission Using Spatial and Molecular Genetic Data.
Journal of Infectious Diseases. ; 213(2):287-294.
Data for action: collection and use of local data to end tuberculosis.
The Lancet. ; 386(10010):2324-2333.
The Distribution of Fitness Costs of Resistance-Conferring Mutations Is a Key Determinant for the Future Burden of Drug-Resistant Tuberculosis: A Model-Based Analysis.
Clinical Infectious Diseases. ; 61(suppl 3):S147-S154.
How competition governs whether moderate or aggressive treatment minimizes antibiotic resistance.
eLife. ; 4:-.
The potential impact of coinfection on antimicrobial chemotherapy and drug resistance.
Trends in Microbiology. ; 23(9):537-544.
How could preventive therapy affect the prevalence of drug resistance? Causes and consequences.
Philosophical Transactions of the Royal Society B: Biological Sciences. ; 370(1670):20140306-.
Evaluating the potential impact of enhancing HIV treatment and tuberculosis control programmes on the burden of tuberculosis.
Journal of The Royal Society Interface. ; 12(106):20150146-.
The Impact of Antiretroviral Therapy on Mortality in HIV Positive People during Tuberculosis Treatment: A Systematic Review and Meta-Analysis.
PLoS ONE. ; 9(11):e112017-.
The path of least resistance: aggressive or moderate treatment?.
Proceedings of the Royal Society B: Biological Sciences. ; 281(1794):20140566-.
Modeling of Novel Diagnostic Strategies for Active Tuberculosis – A Systematic Review: Current Practices and Recommendations.
PLoS ONE. ; 9(10):e110558-.
The burden of tuberculosis disease in children–Authors' reply.
The Lancet. ; 384(9951):1343-1344.
On the spread and control of MDR-TB epidemics: An examination of trends in anti-tuberculosis drug resistance surveillance data.
Drug Resistance Updates. ; 17(4-6):105-123.
Impact and cost-effectiveness of current and future tuberculosis diagnostics: the contribution of modelling.
The International Journal of Tuberculosis and Lung Disease. ; 18(9):1012-1018.
Incidence of multidrug-resistant tuberculosis disease in children: systematic review and global estimates.
The Lancet. ; 383(9928):1572-1579.
How can mathematical models advance tuberculosis control in high HIV prevalence settings?.
The International Journal of Tuberculosis and Lung Disease. ; 18(5):509-514.
Clinical Tuberculosis.
; :-.
High Rates of Potentially Infectious Tuberculosis and Multidrug-Resistant Tuberculosis (MDR-TB) among Hospital Inpatients in KwaZulu Natal, South Africa Indicate Risk of Nosocomial Transmission.
PLoS ONE. ; 9(3):e90868-.
The potential effects of changing HIV treatment policy on tuberculosis outcomes in South Africa.
AIDS. ; 28:S25-S34.
The Effect of HIV-Related Immunosuppression on the Risk of Tuberculosis Transmission to Household Contacts.
Clinical Infectious Diseases. ; 58(6):765-774.
Assessing spatial heterogeneity of multidrug-resistant tuberculosis in a high-burden country.
European Respiratory Journal. ; 42(5):1291-1301.
A tale of two settings: the role of the Beijing genotype in the epidemiology of multidrug-resistant tuberculosis.
European Respiratory Journal. ; 43(2):632-635.
How the Dynamics and Structure of Sexual Contact Networks Shape Pathogen Phylogenies.
PLoS Computational Biology. ; 9(6):e1003105-.
Identifying dynamic tuberculosis case-finding policies for HIV/TB coepidemics.
Proceedings of the National Academy of Sciences. ; 110(23):9457-9462.
The impact of new tuberculosis diagnostics on transmission: why context matters.
Bulletin of the World Health Organization. ; 90(10):739-747.
Re: Supporting health systems for tuberculosis through research.
Tuberculosis. ; 92(4):290-.
Use of Spatial Information to Predict Multidrug Resistance in Tuberculosis Patients, Peru.
Emerging Infectious Diseases. ; 18(5):811-813.
The dynamics of sexual contact networks: Effects on disease spread and control.
Theoretical Population Biology. ; 81(2):89-96.
A modelling framework to support the selection and implementation of new tuberculosis diagnostic tools [State of the art series. Operational research. Number 8 in the series].
The International Journal of Tuberculosis and Lung Disease. ; 15(8):996-1004.
Test and treat in HIV: success could depend on rapid detection.
The Lancet. ; 378(9787):204-206.
Epidemiologic Inference From the Distribution of Tuberculosis Cases in Households in Lima, Peru.
Journal of Infectious Diseases. ; 203(11):1582-1589.
Spontaneous Emergence of Multiple Drug Resistance in Tuberculosis before and during Therapy.
PLoS ONE. ; 6(3):e18327-.
Assessing spatiotemporal patterns of multidrug-resistant and drug-sensitive tuberculosis in a South American setting.
Epidemiology and Infection. ; 139(11):1784-1793.
AIDS and Tuberculosis.
; :253-275.
No coexistence for free: Neutral null models for multistrain pathogens.
Epidemics. ; 1(1):2-13.
** EXPEDITED REVIEW ** || Adaptive policies to balance health benefits and economic costs of physical distancing interventions during the COVID-19 pandemic.
Medical decision making : an international journal of the Society for Medical Decision Making. .
The effect of drug resistance on the fitness of Mycobacterium tuberculosis.
Lancet Infect Dis.
2003 Jan;3(1):13-21. doi: 10.1016/s1473-3099(03)00483-3. Review. PubMed PMID:
12505028; NIHMSID:NIHMS94739.
Transmission dynamics and control of severe acute respiratory syndrome.
Science.
2003 Jun 20;300(5627):1966-70. doi: 10.1126/science.1086616. Epub 2003 May 23. PubMed PMID:
12766207; PubMed Central PMCID:
PMC2760158.
Isoniazid resistance and the future of drug-resistant tuberculosis.
Microb Drug Resist.
2004 Winter;10(4):280-5. doi: 10.1089/mdr.2004.10.280. PubMed PMID:
15650371; PubMed Central PMCID:
PMC2652757.
Modeling epidemics of multidrug-resistant M. tuberculosis of heterogeneous fitness.
Nat Med.
2004 Oct;10(10):1117-21. doi: 10.1038/nm1110. Epub 2004 Sep 19. PubMed PMID:
15378056; PubMed Central PMCID:
PMC2652755.
What would you like to do?